vs
Side-by-side financial comparison of ENTEGRIS INC (ENTG) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $823.9M, roughly 1.8× ENTEGRIS INC). ENTEGRIS INC runs the higher net margin — 6.0% vs -13.6%, a 19.6% gap on every dollar of revenue. On growth, ENTEGRIS INC posted the faster year-over-year revenue change (-3.1% vs -5.3%). ENTEGRIS INC produced more free cash flow last quarter ($134.0M vs $96.0M). Over the past eight quarters, ENTEGRIS INC's revenue compounded faster (3.4% CAGR vs -3.6%).
Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
ENTG vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $823.9M | $1.5B |
| Net Profit | $49.4M | $-205.0M |
| Gross Margin | 43.8% | 49.2% |
| Operating Margin | 12.7% | -9.8% |
| Net Margin | 6.0% | -13.6% |
| Revenue YoY | -3.1% | -5.3% |
| Net Profit YoY | -51.7% | -288.1% |
| EPS (diluted) | $0.33 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $823.9M | $1.5B | ||
| Q3 25 | $807.1M | $1.6B | ||
| Q2 25 | $792.4M | $1.6B | ||
| Q1 25 | $773.2M | $1.5B | ||
| Q4 24 | $849.8M | $1.6B | ||
| Q3 24 | $807.7M | $1.6B | ||
| Q2 24 | $812.7M | $1.6B | ||
| Q1 24 | $771.0M | $1.6B |
| Q4 25 | $49.4M | $-205.0M | ||
| Q3 25 | $70.5M | $160.0M | ||
| Q2 25 | $52.8M | $145.0M | ||
| Q1 25 | $62.9M | $87.0M | ||
| Q4 24 | $102.2M | $109.0M | ||
| Q3 24 | $77.6M | $359.0M | ||
| Q2 24 | $67.7M | $195.0M | ||
| Q1 24 | $45.3M | $201.0M |
| Q4 25 | 43.8% | 49.2% | ||
| Q3 25 | 43.5% | 53.5% | ||
| Q2 25 | 44.4% | 54.8% | ||
| Q1 25 | 46.1% | 55.6% | ||
| Q4 24 | 45.6% | 56.3% | ||
| Q3 24 | 46.0% | 58.3% | ||
| Q2 24 | 46.2% | 58.4% | ||
| Q1 24 | 45.6% | 59.0% |
| Q4 25 | 12.7% | -9.8% | ||
| Q3 25 | 15.2% | 15.2% | ||
| Q2 25 | 13.4% | 14.4% | ||
| Q1 25 | 15.8% | 6.7% | ||
| Q4 24 | 17.6% | 8.1% | ||
| Q3 24 | 16.9% | 13.1% | ||
| Q2 24 | 16.0% | 14.6% | ||
| Q1 24 | 15.3% | 14.5% |
| Q4 25 | 6.0% | -13.6% | ||
| Q3 25 | 8.7% | 10.0% | ||
| Q2 25 | 6.7% | 9.1% | ||
| Q1 25 | 8.1% | 5.8% | ||
| Q4 24 | 12.0% | 6.8% | ||
| Q3 24 | 9.6% | 22.7% | ||
| Q2 24 | 8.3% | 12.1% | ||
| Q1 24 | 5.9% | 12.4% |
| Q4 25 | $0.33 | $-0.78 | ||
| Q3 25 | $0.46 | $0.61 | ||
| Q2 25 | $0.35 | $0.56 | ||
| Q1 25 | $0.41 | $0.33 | ||
| Q4 24 | $0.67 | $0.42 | ||
| Q3 24 | $0.51 | $1.38 | ||
| Q2 24 | $0.45 | $0.75 | ||
| Q1 24 | $0.30 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $360.4M | $574.0M |
| Total DebtLower is stronger | $3.7B | $8.6B |
| Stockholders' EquityBook value | $4.0B | $752.0M |
| Total Assets | $8.4B | $12.9B |
| Debt / EquityLower = less leverage | 0.94× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $360.4M | $574.0M | ||
| Q3 25 | $399.8M | $672.0M | ||
| Q2 25 | $376.8M | $599.0M | ||
| Q1 25 | $340.9M | $547.0M | ||
| Q4 24 | $329.2M | $675.0M | ||
| Q3 24 | $432.1M | $763.0M | ||
| Q2 24 | $320.0M | $704.0M | ||
| Q1 24 | $340.7M | $575.0M |
| Q4 25 | $3.7B | $8.6B | ||
| Q3 25 | $3.8B | $8.8B | ||
| Q2 25 | $4.0B | $8.9B | ||
| Q1 25 | $4.0B | $9.0B | ||
| Q4 24 | $4.0B | $8.9B | ||
| Q3 24 | $4.1B | $8.7B | ||
| Q2 24 | $4.1B | $8.7B | ||
| Q1 24 | $4.2B | $8.7B |
| Q4 25 | $4.0B | $752.0M | ||
| Q3 25 | $3.9B | $906.0M | ||
| Q2 25 | $3.8B | $733.0M | ||
| Q1 25 | $3.7B | $542.0M | ||
| Q4 24 | $3.7B | $472.0M | ||
| Q3 24 | $3.6B | $493.0M | ||
| Q2 24 | $3.5B | $144.0M | ||
| Q1 24 | $3.4B | $48.0M |
| Q4 25 | $8.4B | $12.9B | ||
| Q3 25 | $8.4B | $13.6B | ||
| Q2 25 | $8.4B | $13.5B | ||
| Q1 25 | $8.4B | $13.2B | ||
| Q4 24 | $8.4B | $13.1B | ||
| Q3 24 | $8.5B | $12.8B | ||
| Q2 24 | $8.3B | $12.2B | ||
| Q1 24 | $8.4B | $11.9B |
| Q4 25 | 0.94× | 11.49× | ||
| Q3 25 | 0.99× | 9.74× | ||
| Q2 25 | 1.05× | 12.14× | ||
| Q1 25 | 1.06× | 16.52× | ||
| Q4 24 | 1.08× | 18.81× | ||
| Q3 24 | 1.15× | 17.75× | ||
| Q2 24 | 1.18× | 60.11× | ||
| Q1 24 | 1.22× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $192.0M | $141.0M |
| Free Cash FlowOCF − Capex | $134.0M | $96.0M |
| FCF MarginFCF / Revenue | 16.3% | 6.4% |
| Capex IntensityCapex / Revenue | 7.0% | 3.0% |
| Cash ConversionOCF / Net Profit | 3.89× | — |
| TTM Free Cash FlowTrailing 4 quarters | $396.2M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $192.0M | $141.0M | ||
| Q3 25 | $249.5M | $264.0M | ||
| Q2 25 | $113.5M | $220.0M | ||
| Q1 25 | $140.4M | $75.0M | ||
| Q4 24 | $176.1M | $390.0M | ||
| Q3 24 | $197.2M | $141.0M | ||
| Q2 24 | $111.2M | $332.0M | ||
| Q1 24 | $147.2M | $76.0M |
| Q4 25 | $134.0M | $96.0M | ||
| Q3 25 | $182.8M | $218.0M | ||
| Q2 25 | $47.0M | $181.0M | ||
| Q1 25 | $32.4M | $43.0M | ||
| Q4 24 | $68.6M | $335.0M | ||
| Q3 24 | $115.0M | $99.0M | ||
| Q2 24 | $51.9M | $300.0M | ||
| Q1 24 | $80.6M | $30.0M |
| Q4 25 | 16.3% | 6.4% | ||
| Q3 25 | 22.6% | 13.6% | ||
| Q2 25 | 5.9% | 11.4% | ||
| Q1 25 | 4.2% | 2.8% | ||
| Q4 24 | 8.1% | 21.0% | ||
| Q3 24 | 14.2% | 6.3% | ||
| Q2 24 | 6.4% | 18.7% | ||
| Q1 24 | 10.4% | 1.8% |
| Q4 25 | 7.0% | 3.0% | ||
| Q3 25 | 8.3% | 2.9% | ||
| Q2 25 | 8.4% | 2.4% | ||
| Q1 25 | 14.0% | 2.1% | ||
| Q4 24 | 12.7% | 3.5% | ||
| Q3 24 | 10.2% | 2.7% | ||
| Q2 24 | 7.3% | 2.0% | ||
| Q1 24 | 8.6% | 2.8% |
| Q4 25 | 3.89× | — | ||
| Q3 25 | 3.54× | 1.65× | ||
| Q2 25 | 2.15× | 1.52× | ||
| Q1 25 | 2.23× | 0.86× | ||
| Q4 24 | 1.72× | 3.58× | ||
| Q3 24 | 2.54× | 0.39× | ||
| Q2 24 | 1.64× | 1.70× | ||
| Q1 24 | 3.25× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
OGN
Segment breakdown not available.
